NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA
and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED).
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED).
- Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own.
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .